Modus Therapeutics: SEVUSMART study of sevuparin in children with severe malaria published in Nature CommunicationsOctober 22, 2026
General Modus Therapeutics: SEVUSMART study of sevuparin in children with severe malaria published in Nature CommunicationsBy Healthcare Propulsion StaffOctober 22, 20260 Modus Therapeutics Holding AB (publ) announces that the manuscript based on the Phase Ib study SEVUSMART in severe malaria, lead-authored…
General Covid-19: ‘Lessons need to be learnt’ as care home report publishedBy Healthcare Propulsion StaffOctober 21, 20260 Lessons need to be learnt after an inquiry found that government failings in care settings allowed the spread of Covid,…
